Systematic assessment in an animal model of the angiogenic potential of different human cell sources for therapeutic revascularization

Stem Cell Research and Therapy

Volumn 3, Issue 4, 2012, Pages

  Barclay, G Robin ^a   Tura, Olga ^a   Samuel, Kay ^a   Hadoke, Patrick W F ^b   Mills, Nicholas L ^b   Newby, David E ^b   Turner, Marc L ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; LEUKOCYTE ANTIGEN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CD34 SELECTION; CELL DENSITY; CELL DIFFERENTIATION; CELL POPULATION; CELL TRANSPLANTATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOBILIZED PERIPHERAL BLOOD; MONONUCLEAR CELL; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVASCULARIZATION; UMBILICAL CORD BLOOD; ANIMAL; BLOOD CELL; BLOOD VESSEL; BONE MARROW CELL; CELL CULTURE; CELL PROLIFERATION; CULTURE TECHNIQUE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; ENDOTHELIUM CELL; FETUS BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR DISEASES;

ANIMALIA; MUS;

ANIMALS; ANTIGENS, CD; BLOOD CELLS; BLOOD VESSELS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FETAL BLOOD; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR DISEASES;

EID: 84865261357     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt114     Document Type: Article

References (50)

1. Isolation of putative progenitor endothelial cells for angiogenesis. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM, Science 1997 275 964 967 10.1126/science.275.5302.964 9020076
2. Evidence for circulating bone marrow-derived endothelial cells. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP, Blood 1998 92 362 367 9657732
3. The hemangioblast: cradle to clinic. Cogle CR, Scott EW, Exp Hematol 2004 32 885 890 10.1016/j.exphem.2004.07.014 15504543
4. Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Kawamura A, Horie T, Tsuda I, Ikeda A, Egawa H, Imamura E, Iida J, Sakata H, Tamaki T, Kukita K, Meguro J, Yonekawa M, Kasai M, Ther Apher Dial 2005 9 59 63 10.1111/j.1774-9987.2005. 00218.x 15828908
5. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Rafii S, Lyden D, Nat Med 2003 9 702 712 10.1038/nm0603-702 12778169
6. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher AM, J Am Coll Cardiol 2004 44 1690 1699 10.1016/j.jacc.2004.08.014 15489105
7. Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy. Alaiti MA, Masakazu Ishikawa, Costa Marco A, Translational Research 2010 156 112 129 10.1016/j.trsl.2010.06.008 20801408
8. Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy current status and future developments. Templin C, Luscher TF, Landmesser U, Int J Dev Biol 2011 55 407 417 10.1387/ijdb.103219ct 21553380
9. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Fadini GP, Agostini C, Avogaro A, Atherosclerosis 2010 209 10 17 10.1016/j.atherosclerosis.2009.08.033 19740466
10. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Lawall H, Bramlage P, Amann B, Thromb Haemost 2010 103 696 709 10.1160/TH09-10-0688 20174766
11. Endothelial progenitor cells - an evolving story. Pearson JD, Microvasc Res 2010 79 162 168 10.1016/j.mvr.2009.12.004 20043930
12. Cell therapies for therapeutic angiogenesis: back to the bench. Sieveking DP, Ng MK, Vasc Med 2009 14 153 166 10.1177/1358863X08098698 19366823
13. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, Bhavsar JR, Yoder MC, Haneline LS, Ingram DA, Exp Hematol 2007 35 1109 1118 10.1016/j.exphem.2007.04.002 17588480
14. The ontogeny of endothelial progenitor cells through flow cytometry. Mund JA, Case J, Curr Opin Hematol 2011 18 166 170 10.1097/MOH.0b013e328345a16a 21423014
15. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere ML, Gillebert TC, Plum J, Vandekerckhove B, Arterioscler Thromb Vasc Biol 2007 27 1572 1579 10.1161/ATVBAHA.107.144972 17495235
16. Relationship of CD34+ cells infused and red blood cell transfusion requirements after autologous peripheral blood stem cell transplants: a novel method of analysis. Dunlop LC, Heller GZ, Transfusion 2012 52 782 786 10.1111/j.1537-2995.2011.03360.x 21978261
17. CD133+ cell content does not influence recovery time after hematopoietic stem cell transplantation. Jaime-Perez JC, Guillermo-Villanueva VA, Mendez-Ramirez N, Chapa-Rodriguez A, Gutierrez-Aguirre H, Gomez-Almaguer D, Transfusion 2009 49 2390 2394 10.1111/j.1537-2995.2009.02292.x 19903294
18. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I, J Hematother 1996 5 213 226 10.1089/scd.1.1996.5.213 8817388
19. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Barcelos LS, Duplaa C, Krankel N, Graiani G, Invernici G, Katare R, Siragusa M, Meloni M, Campesi I, Monica M, Simm A, Campagnolo P, Mangialardi G, Stevanato L, Alessandri G, Emanueli C, Madeddu P, Circ Res 2009 104 1095 1102 10.1161/CIRCRESAHA.108.192138 19342601
20. Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing. Kim JY, Song SH, Kim KL, Maeng YS, Im JE, Yie SW, Ahn YK, Kim DK, Suh W, Cell Transplant 2010 19 1635 1644 10.3727/096368910X516637 20659357
21. Combined implantation of CD34(+) and CD14(+) cells increases neovascularization through amplified paracrine signalling. Krenning G, van der Strate BW, Schipper M, Brouwer LA, Fernandes BC, van Luyn MJ, Harmsen MC, J Tissue Eng Regen Med 2011 doi: 10.1002/term.503
22. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. Sieveking DP, Buckle A, Celermajer DS, Ng MK, J Am Coll Cardiol 2008 51 660 668 10.1016/j.jacc.2007.09.059 18261686
23. Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesis. Small GR, Hadoke PW, Sharif I, Dover AR, Armour D, Kenyon CJ, Gray GA, Walker BR, Proc Natl Acad Sci USA 2005 102 12165 12170 10.1073/pnas.0500641102 16093320
24. Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources. Tura O, Barclay GR, Roddie H, Davies J, Turner ML, J Transl Med 2007 5 37 47 10.1186/1479-5876-5-37 17640360
25. Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy. Tura O, Crawford J, Barclay GR, Samuel K, Hadoke PW, Roddie H, Davies J, Turner ML, J Thromb Haemost 2010 8 1614 1623 10.1111/j.1538-7836.2010.03900.x 20456757
26. Peripheral blood «endothelial progenitor cells» are derived from monocyte/macrophages and secrete angiogenic growth factors. Rehman J, Li J, Orschell CM, March KL, Circulation 2003 107 1164 1169 10.1161/01.CIR. 0000058702.69484.A0 12615796
27. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Rohde E, Bartmann C, Schallmoser K, Reinisch A, Lanzer G, Linkesch W, Guelly C, Strunk D, Stem Cells 2007 25 1746 1752 10.1634/stemcells.2006-0833 17395771
28. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA, Blood 2007 109 1801 1809 10.1182/blood-2006-08-043471 17053059
29. Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture. Zhang SJ, Zhang H, Wei YJ, Su WJ, Liao ZK, Hou M, Zhou JY, Hu SS, Cell Res 2006 16 577 584 10.1038/sj.cr.7310075 16775629
30. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC, Blood 2004 104 2752 2760 10.1182/blood-2004-04-1396 15226175
31. Is it possible to obtain «true endothelial progenitor cells» by in vitro culture of bone marrow mononuclear cells? Zhang SJ, Zhang H, Hou M, Zheng Z, Zhou J, Su W, Wei Y, Hu S, Stem Cells Dev 2007 16 683 690 10.1089/scd.2006.0062 17784841
32. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Melero-Martin JM, De Obaldia ME, Kang SY, Khan ZA, Yuan L, Oettgen P, Bischoff J, Circ Res 2008 103 194 202 10.1161/CIRCRESAHA.108.178590 18556575
33. Genetic background determines mouse strain differences in inflammatory angiogenesis. Marques SM, Campos PP, Castro PR, Cardoso CC, Ferreira MA, Andrade SP, Microvasc Res 2011 82 246 252 10.1016/j.mvr.2011.08.011 21907724
34. A critical analysis of current in vitro and in vivo angiogenesis assays. Staton CA, Reed MW, Brown NJ, Int J Exp Pathol 2009 90 195 221 10.1111/j.1365-2613.2008.00633.x 19563606
35. Identification of endothelial cells and progenitor cell subsets in human peripheral blood. Estes ML, Mund JA, Ingram DA, Case J, Curr Protoc Cytom 2010 Chapter 9 Unit 9.33 1 11
36. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, Yoder MC, Blood 2005 105 2783 2786 10.1182/blood-2004-08-3057 15585655
37. Quantitative in-vivo studies on angiogenesis in a rat sponge model. Andrade SP, Fan TP, Lewis GP, Br J Exp Pathol 1987 68 755 766 2447929
38. Presence of +|-smooth muscle actin-positive endothelial cells in the luminal surface of adult aorta. Azuma K, Ichimura K, Mita T, Nakayama S, Jin WL, Hirose T, Fujitani Y, Sumiyoshi K, Shimada K, Daida H, Sakai T, Mitsumata M, Kawamori R, Watada H, Biochem Biophys Res Comm 2009 380 620 626 10.1016/j.bbrc.2009.01.135 19285011
39. Smooth muscle alpha-actin expression in endothelial cells derived from CD34+ human cord blood cells. Lu X, Dunn J, Dickinson AM, Gillespie JI, Baudouin SV, Stem Cells Dev 2004 13 521 527 15588509
40. Retention of a differentiated endothelial phenotype by outgrowth endothelial cells isolated from human peripheral blood and expanded in long-term cultures. Fuchs S, Hermanns MI, Kirkpatrick CJ, Cell Tissue Res 2006 326 79 92 10.1007/s00441-006-0222-4 16736194
41. Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Reinisch A, Hofmann NA, Obenauf AC, Kashofer K, Rohde E, Schallmoser K, Flicker K, Lanzer G, Linkesch W, Speicher MR, Strunk D, Blood 2009 113 6716 6725 10.1182/blood-2008-09-181362 19321860
42. Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles. Anghelina M, Krishnan P, Moldovan L, Moldovan NI, Am J Pathol 2006 168 529 541 10.2353/ajpath.2006.050255 16436667
43. Time-lapse in vivo imaging of corneal angiogenesis: the role of inflammatory cells in capillary sprouting. Bourghardt PB, Fagerholm P, Traneus-Rockert C, Lagali N, Invest Ophthalmol Vis Sci 2011 52 3060 3068 10.1167/iovs.10-6101 21330652
44. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Melero-Martin JM, Khan ZA, Picard A, Wu X, Paruchuri S, Bischoff J, Blood 2007 109 4761 4768 10.1182/blood-2006-12-062471 17327403
45. Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury. Hagensen MK, Raarup MK, Mortensen MB, Thim T, Nyengaard JR, Falk E, Bentzon JF, Cardiovasc Res 2012 93 223 231 10.1093/cvr/cvr278 22012957
46. Bone marrow-derived cells are not involved in reendothelialized endothelium as endothelial cells after simple endothelial denudation in mice. Tsuzuki M, Basic Res Cardiol 2009 104 601 611 10.1007/s00395-009-0021-7 19333644
47. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, Yla-Herttuala S, Alitalo K, Weissman IL, Salven P, Proc Natl Acad Sci USA 2008 105 6620 6625 10.1073/pnas.0710516105 18443294
48. Both CD133(+) cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells. Sanchez-Guijo FM, Oterino E, Barbado MV, Carrancio S, Lopez-Holgado N, Muntion S, Hernandez-Campo P, Sanchez-Abarca LI, Perez-Simon JA, San Miguel JF, Brinon JG, del Canizo MC, Cell Transplant 2010 19 103 112 10.3727/ 096368909X476869 19818207
49. Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential. Estes ML, Mund JA, Mead LE, Prater DN, Cai S, Wang H, Pollok KE, Murphy MP, An CS, Srour EF, Ingram DA Jr, Case J, Cytometry A 2010 77 831 839 20803735
50. Evidence for the therapeutic potential of ex vivo expanded human endothelial progenitor cells using autologous serum. Shumiya T, Shibata R, Shimizu Y, Ishii M, Kubota R, Shintani S, Murohara T, Circ J 2010 74 1006 1013 10.1253/circj.CJ-09-0584 20215700